Security record · archived quarter
HRMY
Harmony Biosciences Holdings, Inc. · Healthcare · Biotechnology
13Tracked holders
—Δ holders
3.50MShares held
$105.70MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +5 | 37.66M | $1.37B | +12 | −6 |
| Q1 2026 | 110 | -3 | 39.20M | $1.10B | +5 | −9 |
| Q4 2025 | 114 | +1 | 39.01M | $1.46B | +2 | — |
| Q3 2025 | 20 | +1 | 24.69M | $680.58M | +2 | −2 |
| Q2 2025 | 17 | -1 | 23.07M | $729.13M | +1 | −2 |
| Q1 2025 | 15 | +1 | 6.74M | $223.55M | +1 | — |
| Q4 2024 | 14 | -1 | 7.61M | $261.77M | — | −1 |
| Q3 2024 | 14 | +1 | 3.56M | $142.57M | +1 | — |
| Q2 2024 | 13 | — | 3.50M | $105.70M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 748.70K | — | $22.59M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 748.70K | — | $22.59M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 684.32K | — | $20.65M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 595.80K | — | $17.98M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 310.00K | — | $9.35M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 310.00K | — | $9.35M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Millennium Management ✦ | 307.42K | — | $9.27M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 305.61K | — | $9.22M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Marshall Wace ✦ | 305.61K | — | $9.22M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 154.34K | — | $4.66M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 154.34K | — | $4.66M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 154.34K | — | $4.66M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Norges Bank ✦ (passive) | 127.99K | — | $3.86M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 93.36K | — | $2.82M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 85.00K | — | $2.56M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 50.00K | — | $1.51M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 26.13K | — | $788,253 | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Wellington Management ✦ | 26.13K | — | $788,253 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 26.13K | — | $788,253 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Wellington Management ✦ | 26.13K | — | $788,253 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 14.69K | — | $444,000 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 306 holders, 54.70M shares, $1.38B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API